$QSEP
QS Energy, Inc.

2024 Q1 Form 10-Q Financial Statement

#000168316824003436 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $47.00K $55.00K
YoY Change -12.96% -78.76%
% of Gross Profit
Depreciation & Amortization $1.000K $4.000K
YoY Change 0.0% 300.0%
% of Gross Profit
Operating Expenses $47.00K $235.0K
YoY Change -12.96% -54.81%
Operating Profit -$373.0K
YoY Change 55.42%
Interest Expense -$76.00K -$70.00K
YoY Change -19.15% -41.18%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$449.0K -$305.0K
YoY Change 34.43% -52.27%
Income Tax
% Of Pretax Income
Net Earnings -$449.0K -$305.0K
YoY Change 34.43% -52.27%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 393.4M shares 392.5M shares
Diluted Shares Outstanding 393.4M shares

Balance Sheet

Concept 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $78.00K $70.00K
YoY Change -27.1% -47.37%
Cash & Equivalents $78.00K $70.00K
Short-Term Investments
Other Short-Term Assets $11.00K $12.00K
YoY Change -8.33% -36.84%
Inventory
Prepaid Expenses $11.00K $12.00K
Receivables
Other Receivables
Total Short-Term Assets $89.00K $82.00K
YoY Change -25.21% -46.05%
LONG-TERM ASSETS
Property, Plant & Equipment $1.000K $2.000K
YoY Change -80.0% -66.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.000K $2.000K
YoY Change -80.0% -66.67%
TOTAL ASSETS
Total Short-Term Assets $89.00K $82.00K
Total Long-Term Assets $1.000K $2.000K
Total Assets $90.00K $84.00K
YoY Change -27.42% -46.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.256M $2.198M
YoY Change 11.63% 12.03%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $2.234M $2.158M
YoY Change 16.84% 11.24%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.472M $5.328M
YoY Change 11.47% 9.9%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $5.472M $5.328M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $5.472M $5.328M
YoY Change 11.47% 9.9%
SHAREHOLDERS EQUITY
Retained Earnings -$125.8M -$125.4M
YoY Change 1.08% 0.99%
Common Stock $397.9K $392.6K
YoY Change 3.48% 4.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.382M -$5.244M
YoY Change
Total Liabilities & Shareholders Equity $90.00K $84.00K
YoY Change -27.42% -46.84%

Cashflow Statement

Concept 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$449.0K -$305.0K
YoY Change 34.43% -52.27%
Depreciation, Depletion And Amortization $1.000K $4.000K
YoY Change 0.0% 300.0%
Cash From Operating Activities -$170.0K -$139.0K
YoY Change 16.44% -60.51%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $178.0K -4.000K
YoY Change 48.33% -101.72%
NET CHANGE
Cash From Operating Activities -$170.0K -139.0K
Cash From Investing Activities 0.000
Cash From Financing Activities $178.0K -4.000K
Net Change In Cash $8.000K -143.0K
YoY Change -130.77% 20.17%
FREE CASH FLOW
Cash From Operating Activities -$170.0K -$139.0K
Capital Expenditures $0.00
Free Cash Flow -$139.0K
YoY Change -60.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
0-29185
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
QS ENERGY, INC.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-2088326
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
23902 FM 2978
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Tomball
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77375
CY2024Q1 dei City Area Code
CityAreaCode
775
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
300-7647
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
397931803 shares
CY2024Q1 us-gaap Cash
Cash
78000 usd
CY2023Q4 us-gaap Cash
Cash
70000 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
12000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
89000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
82000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
100000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
99000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2000 usd
CY2024Q1 us-gaap Assets
Assets
90000 usd
CY2023Q4 us-gaap Assets
Assets
84000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2256000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2198000 usd
CY2024Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
982000 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
972000 usd
CY2024Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2184000 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2101000 usd
CY2024Q1 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
50000 usd
CY2023Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
57000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5472000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5328000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
5472000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
5328000 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
397931803 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
397931803 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
397932 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
392587 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
120035068 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
119729413 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-125815000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-125366000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-5382000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-5244000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
90000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
84000 usd
CY2024Q1 us-gaap Revenues
Revenues
0 usd
CY2023Q1 us-gaap Revenues
Revenues
0 usd
CY2024Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
326000 usd
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
186000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
54000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-373000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-240000 usd
CY2024Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
76000 usd
CY2023Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
94000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-449000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-334000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
393373111 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
393373111 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
378415835 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
378415835 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4690000 usd
CY2023Q1 qsep Common Stock Issued On Conversion Of Notes Payable
CommonStockIssuedOnConversionOfNotesPayable
144000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
47000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
39000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
9000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-334000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-4785000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-5244000 usd
CY2024Q1 qsep Common Stock Issued On Conversion Of Notes Payable
CommonStockIssuedOnConversionOfNotesPayable
77000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
85000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
4000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
5000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
140000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-449000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-5382000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-449000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-334000 usd
CY2024Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
5000 usd
CY2023Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
9000 usd
CY2024Q1 qsep Fair Value Of Common Stock Issued For Services
FairValueOfCommonStockIssuedForServices
140000 usd
CY2023Q1 qsep Fair Value Of Common Stock Issued For Services
FairValueOfCommonStockIssuedForServices
0 usd
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
15000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
40000 usd
CY2024Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
49000 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
42000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-7000 usd
CY2024Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
10000 usd
CY2023Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
30000 usd
CY2024Q1 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
58000 usd
CY2023Q1 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
59000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-170000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-146000 usd
CY2024Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
4000 usd
CY2023Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
39000 usd
CY2024Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
181000 usd
CY2023Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
90000 usd
CY2024Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
7000 usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
9000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
178000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
120000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
8000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-26000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
70000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
133000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
107000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024Q1 qsep Conversion Of Convertible Notes To Common Stock
ConversionOfConvertibleNotesToCommonStock
77000 usd
CY2023Q1 qsep Conversion Of Convertible Notes To Common Stock
ConversionOfConvertibleNotesToCommonStock
144000 usd
CY2024Q1 qsep Relative Fair Value Of Warrants Issued With Convertible Notes
RelativeFairValueOfWarrantsIssuedWithConvertibleNotes
85000 usd
CY2023Q1 qsep Relative Fair Value Of Warrants Issued With Convertible Notes
RelativeFairValueOfWarrantsIssuedWithConvertibleNotes
47000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-449000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-170000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-5382000 usd
CY2024Q1 us-gaap Notes Payable
NotesPayable
2071000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2256000 usd
CY2024Q1 us-gaap Cash
Cash
78000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_zZv1VxrqDszh" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><b><span style="text-decoration: underline"><span id="xdx_862_z6TLZJkZuNeb">Estimates</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include those related to accruals for potential liabilities, assumptions used in valuing equity instruments issued for financing and services and realization of deferred tax assets, among others. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
81917138 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
77697806 shares
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
54000 usd
CY2024Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1371000 usd
CY2023Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1332000 usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
843000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
794000 usd
CY2024Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
2214000 usd
CY2023Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
2265000 usd
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
30000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
25000 usd
CY2024Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2184000 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2101000 usd
CY2024Q1 us-gaap Debt Instrument Convertible Terms Of Conversion Feature
DebtInstrumentConvertibleTermsOfConversionFeature
As of March 31, 2024, convertible notes payable and accrued interest are convertible into approximately 36,272,510 shares of common stock at conversion rates ranging from $0.02 to $0.48 per share.
CY2024Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
15000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
54000 usd

Files In Submission

Name View Source Status
qsep-20240331_pre.xml Edgar Link unprocessable
0001683168-24-003436-index-headers.html Edgar Link pending
0001683168-24-003436-index.html Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
0001683168-24-003436.txt Edgar Link pending
0001683168-24-003436-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qsenergy_ex3101.htm Edgar Link pending
qsenergy_ex3102.htm Edgar Link pending
qsenergy_ex3200.htm Edgar Link pending
qsenergy_i10q-033124.htm Edgar Link pending
qsep-20240331.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
qsep-20240331_cal.xml Edgar Link unprocessable
qsep-20240331_def.xml Edgar Link unprocessable
qsep-20240331_lab.xml Edgar Link unprocessable
qsenergy_i10q-033124_htm.xml Edgar Link completed